Contact
Please use this form to send email to PR contact of this press release:
Akero Therapeutics to Report Results of Phase 2b SYMMETRY Study in October 2023
TO:
Please use this form to send email to PR contact of this press release:
Akero Therapeutics to Report Results of Phase 2b SYMMETRY Study in October 2023
TO: